交通銀行(601328.SH)增資交通銀行(香港)有限公司獲監管批覆
格隆匯7月15日丨交通銀行(601328.SH)公佈,公司擬向交通銀行(香港)有限公司(以下簡稱“香港子行”)實施分次增資,增資總額不超過300億港元。該增資計劃已經公司股東大會審議批准。
近日,公司收到《中國銀保監會關於交通銀行向交通銀行(香港)有限公司增資的批覆》,中國銀保監會同意公司向香港子行增撥不超過200億港元的資本金。公司將根據上述批覆,及時完成對香港子行200億港元增資事宜。本次增資完成後,香港子行仍是公司全資子公司。
公司後續將根據香港子行經營發展需要,在增資總額不超過300億港元的前提下,適時啟動下一步增資的監管報批工作,並及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.